Medical University of Vienna psychedelic research trials
Data as of 11 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.
Medical University of Vienna is listed with 8 registered studies counted here, in Vienna, Austria. By compound: 1 psilocybin and 7 ketamine. By registry status: 2 recruiting, 2 completed and 4 status not reported. By phase: 3 phase 1, 2 phase 2 and 3 not applicable. Reported start years run from 2011 (earliest) to 2025 (latest).
Institution name, city and country are copied from the research site linked to each registry record. A study counts once per institution, and a study tagged with more than one compound is counted under each compound.
Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.
At a glance
- 8 registered studies are counted on this page.
By compound
| Compound hub | Studies |
|---|---|
| Psilocybin | 1 |
| Ketamine | 7 |
By registry status
| Status | Studies | Share |
|---|---|---|
| Recruiting | 2 | 25% |
| Completed | 2 | 25% |
| Status not reported | 4 | 50% |
By phase
| Phase | Studies | Share |
|---|---|---|
| Phase 1 | 3 | 38% |
| Phase 2 | 2 | 25% |
| Not applicable | 3 | 38% |
Registered studies
All counted studies, newest start first. The order is not a ranking and says nothing about quality. Titles are quoted from the registry. Each ID links to its own ClinicalTrials.gov record, which has the eligibility criteria and contacts.
| Title as registered | Registry ID | Status | Phase | Start | Compound |
|---|---|---|---|---|---|
| Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects | NCT07490353 | Recruiting | Phase 1 | 2025-11-01 | Psilocybin |
| Ketamine in OCD: Efficacy and Effects on Stress and Cognition | NCT05577585 | Recruiting | Not applicable | 2022-10-01 | Ketamine |
| The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects | NCT05320107 | Status not reported | Phase 1 | 2022-06-01 | Ketamine |
| Investigation of Intranasal Ketamine Related Changes in Attentional Brain Networks With Functional and Structural MRI | NCT05320120 | Completed | Phase 1 | 2022-06-01 | Ketamine |
| Add-on Therapy With Edupression.Com® on Therapy Resistant Depressive Patients Treated With Nasal Esketamine Spray | NCT04843462 | Status not reported | Not applicable | 2021-04-29 | Ketamine |
| Investigation of Antidepressant Efficacy of Oral Ketamine Treatment | NCT02992496 | Status not reported | Phase 2 | 2017-04-24 | Ketamine |
| Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter | NCT02717052 | Status not reported | Phase 2 | 2016-05-01 | Ketamine |
| Network Dysfunction, Schizophrenia and Pharmacological Magnetic Resonance Imaging (phMRI) | NCT01394757 | Completed | Not applicable | 2011-08-01 | Ketamine |
About this data
Compound tags come from automated matching of the registry search term and have not been checked record by record. Counts are of registered studies, not of people, results or approvals. A registry listing is not evidence of safety, benefit or results.